Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_provenance.
- NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_assertion description "[Taken together our data suggests that EBBP acts to de-repress transcription of RARbeta2 and CYP26A1, by modifying histone acetylation in retinoid-resistant cancer cells, and, is an important target for drug discovery in retinoid-resistant cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_provenance.
- NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_assertion evidence source_evidence_literature NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_provenance.
- NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_assertion SIO_000772 19147277 NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_provenance.
- NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_assertion wasDerivedFrom befree-20140225 NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_provenance.
- NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_assertion wasGeneratedBy ECO_0000203 NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP632505.RAkvScfifKmiR4tgZvBhJZCEFUdgM036DjOjlkjdanSlQ130_provenance.